272 related articles for article (PubMed ID: 27027353)
1. Cyclin-dependent kinase 5 stabilizes hypoxia-inducible factor-1α: a novel approach for inhibiting angiogenesis in hepatocellular carcinoma.
Herzog J; Ehrlich SM; Pfitzer L; Liebl J; Fröhlich T; Arnold GJ; Mikulits W; Haider C; Vollmar AM; Zahler S
Oncotarget; 2016 May; 7(19):27108-21. PubMed ID: 27027353
[TBL] [Abstract][Full Text] [Related]
2. γ-H2AX promotes hepatocellular carcinoma angiogenesis via EGFR/HIF-1α/VEGF pathways under hypoxic condition.
Xiao H; Tong R; Ding C; Lv Z; Du C; Peng C; Cheng S; Xie H; Zhou L; Wu J; Zheng S
Oncotarget; 2015 Feb; 6(4):2180-92. PubMed ID: 25537504
[TBL] [Abstract][Full Text] [Related]
3. BMP9-ID1 Signaling Activates HIF-1α and VEGFA Expression to Promote Tumor Angiogenesis in Hepatocellular Carcinoma.
Chen H; Nio K; Tang H; Yamashita T; Okada H; Li Y; Doan PTB; Li R; Lv J; Sakai Y; Yamashita T; Mizukoshi E; Honda M; Kaneko S
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163396
[TBL] [Abstract][Full Text] [Related]
4. Bclaf1 promotes angiogenesis by regulating HIF-1α transcription in hepatocellular carcinoma.
Wen Y; Zhou X; Lu M; He M; Tian Y; Liu L; Wang M; Tan W; Deng Y; Yang X; Mayer MP; Zou F; Chen X
Oncogene; 2019 Mar; 38(11):1845-1859. PubMed ID: 30367150
[TBL] [Abstract][Full Text] [Related]
5. 2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2.
Ma L; Li G; Zhu H; Dong X; Zhao D; Jiang X; Li J; Qiao H; Ni S; Sun X
Cancer Lett; 2014 Dec; 355(1):96-105. PubMed ID: 25218350
[TBL] [Abstract][Full Text] [Related]
6. Metformin suppresses hypoxia-induced stabilization of HIF-1α through reprogramming of oxygen metabolism in hepatocellular carcinoma.
Zhou X; Chen J; Yi G; Deng M; Liu H; Liang M; Shi B; Fu X; Chen Y; Chen L; He Z; Wang J; Liu J
Oncotarget; 2016 Jan; 7(1):873-84. PubMed ID: 26621849
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA UBE2CP3 enhances HCC cell secretion of VEGFA and promotes angiogenesis by activating ERK1/2/HIF-1α/VEGFA signalling in hepatocellular carcinoma.
Lin J; Cao S; Wang Y; Hu Y; Liu H; Li J; Chen J; Li P; Liu J; Wang Q; Zheng L
J Exp Clin Cancer Res; 2018 Jun; 37(1):113. PubMed ID: 29866133
[TBL] [Abstract][Full Text] [Related]
8. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.
Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B
J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718
[TBL] [Abstract][Full Text] [Related]
9. Effects of the knockdown of hypoxia inducible factor-1α expression by adenovirus-mediated shRNA on angiogenesis and tumor growth in hepatocellular carcinoma cell lines.
Choi SH; Shin HW; Park JY; Yoo JY; Kim DY; Ro WS; Yun CO; Han KH
Korean J Hepatol; 2010 Sep; 16(3):280-7. PubMed ID: 20924210
[TBL] [Abstract][Full Text] [Related]
10. The transcription factor ZFHX3 is crucial for the angiogenic function of hypoxia-inducible factor 1α in liver cancer cells.
Fu C; An N; Liu J; A J; Zhang B; Liu M; Zhang Z; Fu L; Tian X; Wang D; Dong JT
J Biol Chem; 2020 May; 295(20):7060-7074. PubMed ID: 32277050
[TBL] [Abstract][Full Text] [Related]
11. HIF-1α plays a role in the chemotactic migration of hepatocarcinoma cells through the modulation of CXCL6 expression.
Tian H; Huang P; Zhao Z; Tang W; Xia J
Cell Physiol Biochem; 2014; 34(5):1536-46. PubMed ID: 25323032
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of tumour angiogenesis and growth by small hairpin HIF-1α and IL-8 in hepatocellular carcinoma.
Choi SH; Kwon OJ; Park JY; Kim DY; Ahn SH; Kim SU; Ro SW; Kim KS; Park JH; Kim S; Yun CO; Han KH
Liver Int; 2014 Apr; 34(4):632-42. PubMed ID: 24321089
[TBL] [Abstract][Full Text] [Related]
13. Targeting cyclin dependent kinase 5 in hepatocellular carcinoma--A novel therapeutic approach.
Ehrlich SM; Liebl J; Ardelt MA; Lehr T; De Toni EN; Mayr D; Brandl L; Kirchner T; Zahler S; Gerbes AL; Vollmar AM
J Hepatol; 2015 Jul; 63(1):102-13. PubMed ID: 25660209
[TBL] [Abstract][Full Text] [Related]
14. The epigallocatechin gallate derivative Y
Liao ZH; Zhu HQ; Chen YY; Chen RL; Fu LX; Li L; Zhou H; Zhou JL; Liang G
J Ethnopharmacol; 2020 Sep; 259():112852. PubMed ID: 32278759
[TBL] [Abstract][Full Text] [Related]
15. Sorafenib inhibits hypoxia-inducible factor-1α synthesis: implications for antiangiogenic activity in hepatocellular carcinoma.
Liu LP; Ho RL; Chen GG; Lai PB
Clin Cancer Res; 2012 Oct; 18(20):5662-71. PubMed ID: 22929805
[TBL] [Abstract][Full Text] [Related]
16. Canagliflozin Modulates Hypoxia-Induced Metastasis, Angiogenesis and Glycolysis by Decreasing HIF-1α Protein Synthesis via AKT/mTOR Pathway.
Luo J; Sun P; Zhang X; Lin G; Xin Q; Niu Y; Chen Y; Xu N; Zhang Y; Xie W
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948132
[TBL] [Abstract][Full Text] [Related]
17. CDK5-mediated phosphorylation and stabilization of TPX2 promotes hepatocellular tumorigenesis.
Wang F; Zhao W; Gao Y; Zhou J; Li H; Zhang G; Guo D; Xie C; Li J; Yin Z; Zhang J
J Exp Clin Cancer Res; 2019 Jul; 38(1):286. PubMed ID: 31272499
[TBL] [Abstract][Full Text] [Related]
18. Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma: importance of angiopoietin-2 and hypoxia-induced factor-1 alpha.
Wada H; Nagano H; Yamamoto H; Yang Y; Kondo M; Ota H; Nakamura M; Yoshioka S; Kato H; Damdinsuren B; Tang D; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Nakamori S; Sakon M; Dono K; Wakasa K; Monden M
Liver Int; 2006 May; 26(4):414-23. PubMed ID: 16629644
[TBL] [Abstract][Full Text] [Related]
19. Regulation of COX-2 expression and epithelial-to-mesenchymal transition by hypoxia-inducible factor-1α is associated with poor prognosis in hepatocellular carcinoma patients post TACE surgery.
Huang M; Wang L; Chen J; Bai M; Zhou C; Liu S; Lin Q
Int J Oncol; 2016 May; 48(5):2144-54. PubMed ID: 26984380
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of HDAC6 promotes angiogenesis in hepatocellular carcinoma cells and predicts poor prognosis in liver transplantation patients.
Lv Z; Weng X; Du C; Zhang C; Xiao H; Cai X; Ye S; Cheng J; Ding C; Xie H; Zhou L; Wu J; Zheng S
Mol Carcinog; 2016 May; 55(5):1024-33. PubMed ID: 26086159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
